Brixton Biosciences

Brixton Biosciences is a clinical-stage life sciences company developing novel therapies for pain treatment. Their flagship product, Neural Ice, is a non-opioid, injectable solution offering long-lasting pain relief, addressing the urgent need for alternatives to opioid-based pain management.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: $2M

Date: 24-Oct-2024

Investors: National Institutes of Health (NIH)

Markets: Biotechnology, Pain Management, Healthtech

HQ: Cambridge, Massachusetts, United States

Founded: 2019

Website: https://www.brixtonbio.com/

LinkedIn: https://www.linkedin.com/company/brixtonbiosciences

Twitter:

Instagram: